Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Quality & Compliance 
Home / Quality & Compliance / Intellectual Property
Intellectual Property 
Formosa Laboratories, Inc. respects the intellectual property of others, and we ask our users and customers to do the same.

 Baricitinib

Patent number Country
US10766900B2 US
TWI781345 TW

Calcipotriol

Patent number Country
DE102006047173B4 DE
CN100404686C CN
CN1948283B CN
 

 Fondaparinux

Patent number Country
TWI628187 TW
US10023603B2 US
 

 Maxacalcitol

Patent number Country
JP5563324B2 JP
JP5652723B2 JP
TWI461396B TW
 

Montelukast Na

Patent number Country
US7700776B2 US
US8399675B2 US
US7271268B1 US
DE102007061630B4 DE
CN101323589B CN
CN101817818B CN
CN101845024B CN
 

 Nilotinib

Patent number Country
US9187452B1 US
 

Paricalcitol

Patent number Country
US7491712B1 US
US7645911B2 US
US8026379B2 US
DE102008061497B4 DE
TWI1367205B TW
DE102009013609B4 DE
 

 Pazopanib Hydrochloride

Patent number Country
US10626110B2 US
 

 Ribociclib

Patent number Country
TWI718533B TW
 

 Rucaparib Camsylate

Patent number Country
US11021483B2 US
 

 Sugammadex Sodium

Patent number Country
US10233263B1 US
US10336835B2 US
TWI703163B TW
 


 



 
 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝